IL33 and systemic sclerosis: Of note is the loss of IL-33-related metabolic associations specific to SSc-PAH.<h4>Discussion</h4>This study identified a candidate biomarker panel comprising three cytokines and ten metabolites capable of differentiating between SSc-PAH, SSc-PF, SSc-NLD, and HC.